Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
This was the stock's second consecutive day of gains.
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Philip Morris International Inc. (PM) stock saw a decline, ending the day at $117.15 which represents a decrease of $-4.71 or -3.87% from the prior close of $121.86. The stock opened at $119.96 and ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...